Two Sigma Securities’s Apellis Pharmaceuticals APLS Stock Holding History

Two Sigma Securities’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23,779	Closed	-$957K	–	1711
2026 Q1	$957K	Buy	+23,779	New	+$512K	0.11%	225
2025 Q3	–	Sell	-21,168	Closed	-$366K	–	1370
2025 Q2	$366K	Buy	+21,168	New	+$392K	0.05%	568
2023 Q3	–	Sell	-2,217	Closed	-$202K	–	2901
2023 Q2	$202K	Buy	+2,217	New	+$191K	﹤0.01%	2220

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Securities's APLS Position: Q2 2026 in Review

Two Sigma Securities sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 23,779 shares — an estimated $957K sold.

Two Sigma Securities first reported a position in APLS in Q2 2023 and held it in 3 quarters. The position peaked at $957K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Two Sigma Securities reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 23,779 Apellis Pharmaceuticals shares in Q2 2026, an estimated $957K.
Two Sigma Securities first reported a position in Apellis Pharmaceuticals in Q2 2023 and held it in 3 quarters.
Two Sigma Securities's Apellis Pharmaceuticals position peaked at $957K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.